Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,378

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

for

Bladder (Urothelial, Transitional Cell) Cancer,

Location: St Louis MO, Little Rock AR, Atlanta GA, Arlington TX,

Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT07480356

Phase3, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for

Graves' Disease

Location: St Louis MO, Jefferson City MO, Kansas City MO,

Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07018323

Phase2, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for

Atrial Fibrillation (AF)

Location: St Louis MO, Evansville IN, Memphis TN, Kansas City MO,

Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,

Location: St Louis MO, Quincy IL, Champaign IL, Evansville IN,

Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

for

Acute Ischemic Stroke

Location: St Louis MO, Chicago IL, Kalamazoo MI, Tulsa OK,

Sponsor: Corxel Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06990867

Phase2, Phase3, Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

for

Candidemia, Candidiasis, Invasive

Location: St Louis MO, Indianapolis IN, Birmingham AL,

Sponsor: Basilea Pharmaceutica

Sex: All

Age: 18+

Code: NCT05421858

Phase3, Recruiting

LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

for

Syphilis Infection, Benzathine Penicillin Adverse Reaction

Location: Saint Louis MO

Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06391125

Phase3, Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

for

HIV Infections

Location: St Louis MO, Kansas City MO, Chicago IL, Cincinnati OH,

Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07473778

Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

for

Invasive Mold Infections

Location: St Louis MO, Chicago IL, Lexington KY, Birmingham AL,

Sponsor: Basilea Pharmaceutica

Sex: All

Age: 18+

Code: NCT06925321

Phase3, Recruiting

Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg

for

Compartment Syndrome

Location: St. Louis MO, Memphis TN, Maywood IL, Minneapolis MN,

Sponsor: Twin Star Medical, Inc.

Sex: All

Age: 18 - 60

Code: NCT00681616

Recruiting

New

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for

Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma

Location: St Louis MO, Creve Coeur MO, O'Fallon IL, Shiloh IL,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase3, Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,

Location: St Louis MO, Creve Coeur MO, Shiloh IL,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

for

Anatomic Stage III Breast Cancer AJCC v8,

Location: St Louis MO, Seattle WA

Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06179303

Phase2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for

Breast Cancer

Location: St Louis MO, Oxford MS, Memphis TN, Louisville KY,

Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

for

Acute Myeloid Leukemia, Myelodysplastic Syndrome

Location: St Louis MO, Chicago IL, Toronto, Houston TX,

Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06419634

Phase1, Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for

mCRPC (Metastatic Castration-resistant Prostate Cancer),

Location: St Louis MO, Indianapolis IN, Chicago IL, Omaha NE,

Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase1, Phase2, Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

for

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Neoplasm,

Location: St Louis MO, Creve Coeur MO, Shiloh IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687123

Phase1, Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for

Advanced Malignant Solid Neoplasm,

Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for

AL Amyloidosis

Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

for

Clinical Stage III Cutaneous Melanoma AJCC v8,

Location: St Louis MO, Creve Coeur MO, Shiloh IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05896839

Phase1, Phase2, Recruiting

Paid Clinical Trials St. Louis

Filter results

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Interested in new trials?

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer